tert-Butyl (1R*,4R*)-4-(2-methylbenzylamino)cyclohexylcarbamate, 1g

1-(3,4-Dichlorophenyl)ethanol, 95.0%, 1g

2-(2-Ethoxyethyl)pyridine, 95%, 250mg

(3-Cyano-4-hydroxyphenyl)boronic acid, 97%, 1g

L-lysine monohydrate, min. 98.5%, for biochemistry, 100 g, plastic packaging.

2-Chloro-N-methyl-N-(4-methylcyclohexyl)acetamide, 98%, 100mg

5-Bromo-2-methylbenzyl alcohol, 95%, 100mg

4-Amino-N-(tert-butyl)-3-isopropyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-1-carboxamide, 95.0%, 100mg

2-(2-Aminoethylamino)ethanol, min 98%, for synthesis, 1 L, glass packaging

(2R,3R)-3-FLUORO-2-METHYLAZETIDINE HYDROCHLORIDE, 95%, 500mg

(S)-3-Amino-4-((carboxymethyl)amino)-4-oxobutanoic acid, 95%, 250mg

1-BUTYL-3-METHYL-1H-IMIDAZOL-3-IUM TRIFLUOROMETHANESULFONATE, 95%, 25g

(1-Methylethenyl)-benzene contains 15 ppm p-tert-butylcatechol as inhibitor, 95.0%, 10g